ArticleInvestigational new drugs2020

A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma.

Emilie M J van Brummelen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.